Prognostic factors of second primary contralateral breast cancer in early-stage breast cancer

被引:1
|
作者
Li, Zheng [1 ]
Sergent, Fabrice [2 ]
Bolla, Michel [3 ]
Zhou, Yunfeng [1 ]
Gabelle-Flandin, Isabelle [3 ]
机构
[1] Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan 430071, Hubei, Peoples R China
[2] Grenoble Univ, Cent Hosp, Dept Gynecol, F-38043 Grenoble, France
[3] Grenoble Univ, Cent Hosp, Dept Radiat Oncol, F-38043 Grenoble, France
关键词
breast cancer; radiotherapy; contralateral breast cancer; risk factors; RADIATION-THERAPY; POSTMENOPAUSAL WOMEN; CONSERVING SURGERY; CLINICAL UTILITY; RISK; TAMOXIFEN; PAI-1; UPA; EPIDEMIOLOGY; BRCA1;
D O I
10.3892/ol.2014.2623
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of the present study was to investigate the therapeutic outcome of early-stage breast cancer (pT1aN0M0) and to identify prognostic factors for secondary primary contralateral breast cancer (CBC). A total of 85 patients with mammary carcinomas were included. All patients had undergone breast surgery and adjuvant treatment between January 2001 and December 2008 at the Central Hospital of Grenoble University (Grenoble, France). The primary end-points were disease-free survival and secondary CBC, and the potential prognostic factors were investigated. During a median follow-up of 60 months, 10 of the 85 patients presented with secondary primary cancer, of which six suffered with CBC. No patient mortalities were reported. The rates of CBC were 2.35, 3.53 and 7.06% at one, two and five years, respectively. The cumulative univariate analysis showed that microinvasion and family history are potential risk factors for newly CBC. The current study also demonstrated that secondary CBC was more likely to occur in patients with microinvasion or a family history of hte dise. In addition, the systematic treatment of secondary CBC should include hormone therapy.
引用
收藏
页码:245 / 251
页数:7
相关论文
共 50 条
  • [21] Update on the management of early-stage breast cancer
    Heilat, Ghaith Bahjat
    Brennan, Meagan E.
    French, James
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2019, 48 (09) : 604 - 608
  • [22] Improving Outcomes in Early-Stage Breast Cancer
    Glueck, Stefan
    Mamounas, Terry
    Klem, Jennifer
    ONCOLOGY-NEW YORK, 2010, 24 (11): : 5 - 15
  • [23] Predictive and prognostic factors in the treatment of early breast cancer
    Thomssen, Christoph
    ONKOLOGE, 2021, 27 (12): : 1175 - 1190
  • [24] Preoperative breast MRI in early-stage breast cancer
    Patricia Young
    Benjamin Kim
    Jennifer L. Malin
    Breast Cancer Research and Treatment, 2012, 135 : 907 - 912
  • [25] Rising Rates of Contralateral Prophylactic Mastectomy as a Treatment for Early-Stage Breast Cancer
    Jerome-D'Emilia, Bonnie
    Kushary, Debashis
    Suplee, Patricia D.
    CANCER NURSING, 2019, 42 (01) : 12 - 19
  • [26] Annual surveillance mammography after early-stage breast cancer and breast cancer mortality
    Paszat, L. F.
    Sutradhar, R.
    Gu, S.
    Rakovitch, E.
    CURRENT ONCOLOGY, 2016, 23 (06) : E538 - E545
  • [27] Local control in young women with early-stage breast cancer treated with hypofractionated whole breast irradiation
    Rock, Kathy
    Ng, Sylvia
    Murray, Louise
    Su, Jie
    Fyles, Anthony
    Koch, C. Anne
    BREAST, 2018, 41 : 89 - 92
  • [28] Outcomes with intraoperative radiation therapy for early-stage breast cancer
    Obi, Elizabeth
    Tom, Martin C.
    Manyam, Bindu, V
    Grobmyer, Stephen R.
    Al-Hilli, Zahraa
    Valente, Stephanie
    Fanning, Alicia
    Radford, Diane M.
    Cherian, Sheen
    Tendulkar, Rahul D.
    Shah, Chirag
    BREAST JOURNAL, 2020, 26 (03) : 454 - 457
  • [29] Hypofractionated Radiation Therapy in the Treatment of Early-Stage Breast Cancer
    Freedman, Gary M.
    CURRENT ONCOLOGY REPORTS, 2012, 14 (01) : 12 - 19
  • [30] Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: the Life After Cancer Epidemiology study
    Kwan, Marilyn L.
    Greenlee, Heather
    Lee, Valerie S.
    Castillo, Adrienne
    Gunderson, Erica P.
    Habel, Laurel A.
    Kushi, Lawrence H.
    Sweeney, Carol
    Tam, Emily K.
    Caan, Bette J.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 130 (01) : 195 - 205